The Tricuspid Regurgitation: Repair vs. Replacement course is a collection of five modules aiming to provide learners with insights into the diagnosis and management of tricuspid regurgitation. The course includes lectures, case discussions, and advanced echocardiographic imaging techniques to enhance clinical decision-making.

Faculty:

• Qiong Zhao , MD, PhD, FACC, FASE
• Sheela Pai Cole MD, FASA, FASE
• Andrew Notarianni MD, FASA, FASE
• Kameswari Maganti MD, FACC, FASE
• G. Burkhard Mackensen MD, PhD, FSCAI, FASE
• Jyothy Puthumana MD, FASE
• Eric Sarin MD
• Charles Nyman MD
• Zuyue Wang MD, FASE

CME Information: 2.5 AMA PRA Category 1 Credits™

Release Date: April 23, 2025

Expiration Date: April 23, 2028

Target Audience:

National and international learners in the field of cardiology and echocardiography. Primary content is designed for sonographers and physicians seeking to enhance their understanding of tricuspid regurgitation diagnosis and management. Additional advanced material is targeted towards early and mid-career physicians and sonographers looking to deepen their expertise in surgical and transcatheter intervention options.

Learning Objectives:

1. Provide a comprehensive understanding of the etiology, pathophysiology, classification, and clinical course of tricuspid regurgitation (TR).
2. Enhance knowledge of multimodality imaging for TR, with a focus on advanced echocardiography techniques.
3. Expand proficiency in guidelines for medical, surgical, and transcatheter interventions for TR, including indications, technologies, and clinical outcomes.
4. Strengthen understanding of echocardiography’s role in pre- and postoperative evaluation and intraoperative guidance for TR interventions.
    

Modules:

1. Understanding Tricuspid Valve & Tricuspid Valve Regurgitation
2. Multimodality Imaging for TR: The Essential Role of Echocardiography
3. Medical, Transcatheter and Surgical Interventions for TR
4. Panel Discussion of Specific Cases: Repair or Replacement
5. Challenges & Opportunities in TR Management

Accreditation Statement: 

The American Society of Echocardiography is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Society of Echocardiography designates this activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, the American Board of Pediatrics (ABP) MOC program, and/or the American Board of Anesthesiology’s (ABA) Maintenance of Certification in Anesthesiology Program® or MOCA 2.0®. It is ASE’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC points and/or ABA MOCA 2.0®.   Physicians will earn MOC and/or MOCA 2.0 points equivalent to the amount of CME credits claimed for the activity.

ARDMS and CCI recognize ASE’s certificates and have agreed to honor the CME credit hours toward their registry requirements for sonographers.

Disclosures:

ASE is committed to ensuring that its educational mission, and all accredited continuing educational programs provide a protected space to learn, teach, and engage in scientific discourse free from influence from organizations that may have an incentive to insert commercial bias into education.

While a monetary or professional affiliation with an ineligible company does not necessarily influence a speaker’s presentation, the Standards for Integrity and Independence in Accredited Continuing Education and policies of the ACCME require that all financial relationships with ineligible companies* be identified and mitigated prior to engaging in an accredited CE activity. In accordance with these policies, ASE actively identified relevant financial relationships between faculty in control of this accredited CE activity and ineligible companies and implemented mitigation strategies to eliminate any potential influence from persons or organizations that may have an incentive to insert commercial bias in this activity. (*Companies that are ineligible to be accredited in the ACCME System (“ineligible companies”) are those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.)

The following faculty members have no relevant financial relationships with ineligible companies:

• Qiong Zhao , MD, PhD, FACC, FASE
• Sheela Pai Cole MD, FASA, FASE
• Andrew Notarianni MD, FASA, FASE
• Kameswari Maganti MD, FACC, FASE
• Eric Sarin MD
• Charles Nyman MD
• Zuyue Wang MD, FASE

All relevant financial relationships with ineligible companies listed for the following faculty members have been mitigated:

• G. Burkhard Mackensen MD, PhD, FSCAI, FASE; Philips Healthcare (Research Funding/Support)
• Jyothy Puthumana MD, FASE; Abbott Structural (Speaker/Speaker's Bureau)

Members of the ASE CME Committee members (not serving as faculty) do not have any financial relationships with ineligible companies.  Click here for a list of these members.

None of the ASE staff who were involved in the planning and implementation of this educational activity have relevant financial relationship(s) to disclose with ineligible companies.  Click here for a list of ASE staff members.

No commercial support was provided for this activity.

• Contact:
  ASE Learning Hub